News

A pilot study finds diverse arthritis patterns and high metabolic comorbidity burden in idradenitis suppurativa, with IL-17 inhibitors showing improved outcomes.

Marisol Betensky, MD outlines how institutions can implement risk-stratified guidelines while balancing thrombosis prevention, bleeding risk, and limited evidence.

Mary Pilarz, MD, highlights how allowing families to initiate interpreter use in the PICU boosts utilization and may improve communication equity.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

Findings by Conall Watson, PhD, MSc, highlight that maternal RSV vaccination significantly reduces infant hospitalizations—even when given late in pregnancy.

A nationwide analysis of nearly 300,000 infants found that maternal RSV vaccination reduced severe infant hospitalizations by over 80%.

Jennifer Dantzer, MD, discusses how environmental and genetic factors and clinical features shape the diagnosis and management of seasonal allergies in children.

New evidence using sibling-matched analyses suggests no meaningful association between prenatal acetaminophen use and autism.

Henry Xiang, MD, PhD, highlights the importance of thorough follow-up and family resilience in managing mental health outcomes after traumatic brain injury.

The FDA has approved landiolol for patients younger than 18 years with supraventricular tachycardia, expanding access.

The FDA will review a supplemental application for delgocitinib cream in patients aged 12 to 17 years, supported by phase 3 data showing improved outcomes.

Mary Beth Howard, MD, MSc, says rising injury rates among young adolescents reflect a mismatch among rider maturity, high-speed devices, and unsafe riding environments.

Adolescent and young adult cancer survivors face a 2-fold increased risk of developing new primary malignancies, with persisting risk.

Learn how to spot and treat pediatric insomnia: sleep hygiene first, behavioral tools, and when melatonin or other off-label meds fit.

An analysis found nirsevimab was associated with substantial reductions in RSV-related hospitalizations among preterm infants and those with congenital heart disease.

FDA fully approves sparsentan for FSGS in children 8 years and older, offering the first targeted option and stronger proteinuria drops than irbesartan.

Experts say social media–fueled misinformation and evolving policy landscapes are increasing vaccine hesitancy.

Learn when picky eating signals ARFID or pediatric feeding disorder, key red flags, screening questions, and referral tips beyond the growth chart.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

A review of 6 novel drugs approved by the FDA, with links to coverage from Contemporary Pediatrics and other MJH Life Sciences brands.

New guidance from the American Academy of Dermatology outlines evidence-based strategies for preventing and managing atopic dermatitis in children.

A study of children born preterm found that costs are highest in infancy and shift toward nonmedical and social support expenditures in later childhood.

A study found an initial decline in neurodevelopmental diagnoses during COVID-19 followed by a sustained postpandemic increase.

David Stukus, MD, discusses nutrition risks, early allergen introduction, and evolving dietary strategies for managing pediatric food allergies.

Katharine P. Callahan, MD, MSME, highlights how rapid genomic testing in neonatal intensive care offers critical diagnostic and prognostic insight.

Tami Katzir, PhD, and Rotem Yinon, PhD, discuss emerging evidence that brief kindergarten screening tools can identify dyslexia risk across development.

Combined use of nirsevimab and maternal RSV vaccination was associated with a 43% reduction in RSV-related hospitalizations and ED visits among infants.

In a recent study, later age at ADHD diagnosis was associated with lower GPA, reduced academic attainment, and greater school dropout rates.